# Progress Log

## 2026-09-09 — Session 1

**COMPLETED**
- Repository scaffold: directory structure, `.gitignore` (no raw clinical data/secrets ever committed), core tracking files
- Literature discovery + synthesis: 3 parallel research passes (seed-paper citation chaining; recent 2024-2026 landscape scan across all candidate problem areas; dataset feasibility investigation), yielding:
  - `LITERATURE_MATRIX.csv` — 32 verified papers with structured fields (dataset, N, target, validation, metrics, leakage risk, research gap, star rating)
  - 8 detailed paper notes in `PAPERS/` for the highest-value sources, including one flagged internal metric discrepancy (P0007) left unresolved rather than silently picking a number
  - `RESEARCH_GAPS.md` — 8 evidence-backed gaps, each with supporting sources and a stated confidence level
  - `DATASETS/` — 6 individual dataset files (SEER, MIMIC/eICU, TCGA-BRCA, METABRIC, I-SPY2, All of Us) + 1 summary table covering 9 more candidates (NCDB, Flatiron, BCSC, curatedBreastData, SCAN-B, TriNetX, UCI sets, CPRD)
  - `CANDIDATE_RESEARCH_QUESTIONS.md` — 4 candidate research questions scored across 8 criteria, with an explicit recommendation
  - `LEAKAGE_AUDIT.md` — pre-emptive audit of leakage patterns observed in the literature + hard requirements for our own future pipeline

**IN PROGRESS**
- Nothing actively running; session paused at the Stage 4/5 → Stage 6 human-decision checkpoint, as required by the project brief.

**FAILED**
- WebFetch (full-text retrieval) was blocked for the entire session across all three research agents and every domain tested (PubMed, PMC, journal publishers, arXiv, Google Scholar, even Wikipedia as a control). All literature findings are therefore built from WebSearch result snippets, not independently-read full text. This is flagged in every paper note and dataset file where it affects confidence. If a future session has WebFetch access, prioritize re-verifying: the P0007 metric discrepancy, exact validation methodology for P0002/P0005/P0013, and full-text read of P0023 (the longitudinal-EHR scoping review, content not retrieved this session).

**BLOCKED**
- Stage 6 (dataset acquisition) cannot proceed until the human researcher decides: (1) which candidate research question to commit to, and (2) which dataset to pursue first — several of the strongest-fit datasets (Flatiron, SEER-Medicare, TriNetX, All of Us Controlled Tier) require human-only action (payment, IRB, institutional membership, or identity verification) that cannot be completed autonomously.

**NEXT STEP**
- Await Kevin's decision from the RESEARCH CHECKPOINT (delivered in chat this session). Once a research question + dataset are approved, proceed autonomously to Stage 7 (cohort construction) without further stop-and-ask, per the routine-work autonomy rule (Section 33).

**DECISION MADE (D003, 2026-09-09):** Kevin selected treatment response/pCR
prediction as the research question, and All of Us as the first dataset —
see `DECISIONS.md` D003. This was a deliberate, more ambitious pairing than
the checkpoint's matched recommendation (pCR+I-SPY2, recurrence+All of Us),
flagged accordingly.

## 2026-09-09 — Session 2 (continued)

**COMPLETED**
- Logged decision D003 in `DECISIONS.md`
- Updated `RESEARCH_STATE.md` to Stage 6, with a clear split between what's
  blocked on Kevin (All of Us identity verification) vs. what proceeds
  autonomously
- Added explicit "what Kevin needs to do" access instructions to
  `DATASETS/all_of_us_omop.md`
- Drafted `cohort_definition.md` for the pCR prediction task (index date,
  prediction time, observation window, outcome, censoring, inclusion/
  exclusion) — conceptual, pending data-access confirmation

**IN PROGRESS**
- Feasibility investigation (background agent) into whether All of Us can
  actually support (a) identifying a neoadjuvant-chemotherapy cohort and
  (b) ascertaining pCR/treatment response — this specific pairing was not
  verified in the original dataset-discovery pass and carries real risk

**BLOCKED**
- All of Us data access itself — requires Kevin's personal photo-ID identity
  verification (see `DATASETS/all_of_us_omop.md` for exact steps). No
  cohort can be built against real All of Us data until this is done.

**NEXT STEP**
- Once the feasibility check returns: if All of Us + pCR looks viable,
  finalize `cohort_definition.md` and prepare pilot query/cohort-building
  notebooks for Kevin to run once his Workbench access is active. If not
  viable as-is, present a revised recommendation (e.g., fall back to I-SPY2,
  or keep All of Us but change the specific outcome) before proceeding
  further, since this would be a research-design change significant enough
  to warrant checking back in.

**DECISION REQUIRED FROM KEVIN (superseded below by D004 — see updated ask)**

## 2026-09-09 — Session 2 (continued further): feasibility check returned NOT FEASIBLE

**COMPLETED**
- Feasibility investigation completed: All of Us cannot support pCR
  ascertainment as specified (HIGH confidence). Full findings appended to
  `DATASETS/all_of_us_omop.md`; decision logged as D004 in `DECISIONS.md`.

**BLOCKED**
- Study design decision: whether to (a) fall back to I-SPY2 for pCR
  prediction as originally recommended, (b) keep All of Us but change the
  outcome to something structurally supportable, or (c) pursue a hybrid.
  This is a consequential research-design change and is being put back to
  Kevin rather than decided autonomously, per project brief Section 33.
- All of Us Registered Tier registration + identity verification is STILL
  a live action item for Kevin regardless of which option is chosen, since
  option (b) and the hybrid option (c) both still need it; only pure
  option (a) would make it unnecessary for now.

**NEXT STEP**
- Present revised checkpoint to Kevin with the three options above and a
  recommendation (fall back to I-SPY2). Await his decision before any
  further cohort-design or data-engineering work specific to a dataset.

## 2026-09-09 — Session 2 (continued): reverted to recurrence, EHR required (D005)

**COMPLETED**
- Kevin redirected the research question back to recurrence/relapse
  prediction with an explicit EHR-native dataset requirement. Logged as
  D005 in `DECISIONS.md`. All of Us remains the only free, EHR-native
  candidate (Flatiron is commercial, SEER-Medicare needs DUA+IRB+fee).

**IN PROGRESS**
- Feasibility check (background agent) on the narrower question: can
  recurrence be detected from All of Us STRUCTURED data alone (diagnosis
  codes, treatment-restart patterns), without needing free-text pathology
  reports (the specific thing that ruled out pCR in D004). This is a
  different, more tractable signal than pCR and has precedent elsewhere
  (SEER-Medicare claims-based recurrence-proxy algorithms).

**NEXT STEP**
- Await feasibility check; update `cohort_definition.md` for a recurrence
  target once confirmed, and revise `DATASETS/all_of_us_omop.md` and
  `RESEARCH_STATE.md` accordingly.

## 2026-09-09 — Session 2 (continued further): recurrence feasibility confirmed MEDIUM, cohort v2 drafted (D006)

**COMPLETED**
- Feasibility check returned: recurrence detection from All of Us
  structured data is feasible as a gated pilot (MEDIUM confidence), not
  blocked like pCR was, but with a real care-capture-completeness risk
  (quantified via a 2026 claims-linkage comparison study). Logged as D006.
- Rewrote `cohort_definition.md` (v2) around a time-to-event/censored
  design with a combined multi-signal recurrence-proxy algorithm and a
  mandatory manual validation gate before cohort-scale modeling.
- Updated `DATASETS/all_of_us_omop.md` and `LEAKAGE_AUDIT.md` with the
  full findings and the resulting label-noise mitigation strategy.
- This was treated as routine methodology work (same question, same
  dataset as D005) and completed autonomously; Kevin was informed of the
  finding directly in chat rather than stopped for another decision.

**BLOCKED**
- All of Us Registered Tier access (Kevin's identity verification) — still
  the only real blocker. Once active, the concrete pilot steps in
  `DATASETS/all_of_us_omop.md` are ready to run (check Oncology Module
  population, C77-C79 code completeness, pilot the proxy algorithm, run
  the manual validation gate).

**NEXT STEP**
- Nothing further can proceed on this dataset until Kevin's All of Us
  access is active. In the meantime, could start Stage-9-adjacent prep
  work (baseline model scaffolding in `scripts/`/`configs/`) that doesn't
  require real data, if useful — otherwise session is idle pending Kevin's
  access or further direction.
